APA (7th ed.) Citation

Rotolo, R. A., Ecevitoglu, A., Presby, R. E., Lindgren, H., Mombereau, C., Nicholas, C., . . . Salamone, J. D. (2023). Effort-related effects of chronic administration of the DA D2 receptor antagonist haloperidol via subcutaneous programmable minipumps: Reversal by co-administration of the adenosine A2A antagonist istradefylline. Psychopharmacology, 240(10), 2173. https://doi.org/10.1007/s00213-023-06439-y

Chicago Style (17th ed.) Citation

Rotolo, Renee A., et al. "Effort-related Effects of Chronic Administration of the DA D2 Receptor Antagonist Haloperidol via Subcutaneous Programmable Minipumps: Reversal by Co-administration of the Adenosine A2A Antagonist Istradefylline." Psychopharmacology 240, no. 10 (2023): 2173. https://doi.org/10.1007/s00213-023-06439-y.

MLA (9th ed.) Citation

Rotolo, Renee A., et al. "Effort-related Effects of Chronic Administration of the DA D2 Receptor Antagonist Haloperidol via Subcutaneous Programmable Minipumps: Reversal by Co-administration of the Adenosine A2A Antagonist Istradefylline." Psychopharmacology, vol. 240, no. 10, 2023, p. 2173, https://doi.org/10.1007/s00213-023-06439-y.